compare the after surgery pain prevention effect of two different doses of drug

To Compare The Post Operative Analgesic effect Of Two Different Doses Of Magnesium Sulphate As An Adjuvant To Levobupivacaine In Sub-Arachnoid Block for Infra-Umbilical Surgeries

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043635

Enrollment

Registered

2022-07-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Spinal Anaesthesia: group A:0.5% Isobaric LEVOBUPIVACAINE 15mg+100mg magnesium sulphate diluted in N.S(0.2ml), group B: 0.5% isobaric LEVOBUPIVACAINE 15mg+75mgmagnesium sulphate dilute

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing infra-umbilical surgeries American Society of Anesthesiology (ASA) Grade I and II Hemodyanamically stable

Exclusion criteria

Exclusion criteria: 1. Neurological and musculoskeletal disease. 2. Patients with cardiovascular diseases. 3. Contraindications to regional anesthesia such as patient refusal, local infections/sepsis at the site of lumbar puncture, anatomical disorders of spine, shock, any bleeding disorder and patient on anticoagulants. 4. Hypersensitivity to study drugs 5. Pregnant women

Design outcomes

Primary

Measure	Time frame
To Compare Post Operative Analgesic effect of Two Different Doses of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Sub-Arachnoid Block for Infra-Umbilical SurgeriesTimepoint: from the time of giving spinal anaesthesia till 24 hours postopertively	—

Secondary

Measure	Time frame
ComplicationsTimepoint: from the time of giving spinal anaesthesia till 24 hours postopertively	—

Countries

India

Contacts

Public ContactDr Kanwarvir Singh

Sri Guru Ram Das Institute of Medical Sciences and Research

sunilchawla30@gmail.com9915530033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026